慢性丙型肝炎基因型 1b的临床试验
总计3404个结果
-
Gilead Sciences完全的
-
University of BernRoche Pharma AG; University of Lausanne; University of Basel; Cantonal Hospital of St. Gallen; Waid...完全的
-
National Taiwan University HospitalNational Science Council, Taiwan未知
-
Atea Pharmaceuticals, Inc.撤销丙型肝炎病毒感染 | 丙型肝炎 | 丙型肝炎,慢性 | 慢性丙型肝炎 | 丙肝病毒感染比利时
-
Atea Pharmaceuticals, Inc.完全的
-
Gilead Sciences完全的
-
Bristol-Myers Squibb完全的
-
HaEmek Medical Center, IsraelAbbVie完全的
-
University of FloridaPatient-Centered Outcomes Research Institute; Merck Sharp & Dohme LLC; AbbVie完全的
-
Merck Sharp & Dohme LLC完全的
-
Changi General HospitalNational University Hospital, Singapore完全的
-
Merck Sharp & Dohme LLC完全的
-
Merck Sharp & Dohme LLC完全的
-
Janssen R&D Ireland完全的
-
Association HGE CHU Bordeaux SudUniversity Hospital, Bordeaux完全的
-
Bristol-Myers Squibb完全的
-
Bristol-Myers SquibbPharmasset完全的
-
Biocad完全的
-
Janssen R&D IrelandGilead Sciences完全的
-
Merck Sharp & Dohme LLC完全的
-
Centre hospitalier de l'Université de Montréal...Hoffmann-La Roche; Centre de Recherche du Centre Hospitalier de l'Université de Montréal完全的
-
Third Affiliated Hospital, Sun Yat-Sen University未知
-
Peregrine Pharmaceuticals完全的
-
AbbVie完全的
-
Saint Michael's Medical Center完全的
-
Azienda Ospedaliero Universitaria di Cagliari完全的
-
Hospital de Clinicas de Porto AlegreMinistry of Health, Brazil; TelessaúdeRS / UFRGS; State Secretary of Health of Rio Grande do Sul主动,不招人